Cancer Staging
Highly parallel genomic assays could be used to stage cancers in the future
Published in Biotech Business Week, September 25th, 2006
"Recent developments in highly parallel genome-wide assays are transforming the study of human health and disease. High-resolution whole-genome association studies of complex diseases are finally being undertaken after much hypothesizing about their merit for finding disease loci," scientists writing in the journal Nature Reviews Genetics reported.
"The availability of inexpensive high-density SNP-genotyping arrays has made this feasible. Cancer biology will also be transformed by high-resolution genomic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Healthcare Costs
Survey forecasts health plan costs down but drug plan costs to outpace inflation in 2007 - Market Analysis
Booming European enteral nutrition market provides opportunities for ingredient suppliers - Market Analysis
Global market for DNA oligos tops $700 million annually - Market Analysis
Research and Markets report finds healthcare in China to be extremely uneven - Neuroscience
Alzheimer, Parkinson, dementia targeted in protein study - Alzheimer Disease
Accera initiates phase II trial for age associated memory impairment therapy - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
